Form 4: Bio-Rad Laboratories Chairman John Patience Acquires Shares and Options Following Stock Conversion
SEC Form 4 Filing
John Patience, Chairman of Bio-Rad Laboratories, reports acquisition of common stock and stock options following the conversion of Series A Non-Voting Convertible Preferred Stock.
Summary
- John Patience, Chairman of Bio-Rad Laboratories, filed a Form 4 detailing changes in beneficial ownership.
- The filing reports the acquisition of 217,400 shares of common stock due to the conversion of Series A Non-Voting Convertible Preferred Stock on May 23, 2024, following stockholder approval on May 21, 2024.
- Patience also acquired 46,686 restricted stock units (RSUs) and 37,050 stock options on May 21, 2024, which vest on March 31, 2025, subject to continued service.
- The filing indicates Patience's direct and indirect ownership of Bio-Rad common stock through various entities, including John Patience Living Trust and Patience Enterprises LP.
- Patience disclaims beneficial ownership of shares held by Patience Enterprises LP except to the extent of his pecuniary interest.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing detailing insider transactions. The acquisition of shares and options could be seen as a positive signal, but it's not definitively bullish.
Positives
- The acquisition of shares and options by the Chairman could be interpreted as a sign of confidence in the company's future prospects.
Future Outlook
The RSUs and stock options will vest on March 31, 2025, subject to continued service with the Issuer.
Management Comments
- The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Industry Context
Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transactions reported may influence investor perception of the company's stock.
Key Dates
| Date | Description |
|---|---|
| 07/23/1993 | Date of John Patience Living Trust |
| 05/21/2024 | Date of stockholder approval for conversion of Preferred Stock and grant date of RSUs and stock options |
| 05/23/2024 | Date of conversion of Series A Non-Voting Convertible Preferred Stock into Common Stock |
| 05/23/2024 | Date of filing |
| 03/31/2025 | Vesting date for RSUs and stock options |
| 05/20/2034 | Expiration date for stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.